DSP Trustee Private Limited on behalf of schemes of DSP Mutual Fund
Alembic Pharmaceuticals Limited · NSE
−1,36,574 sh
ICICI Prudential Healthcare Fund
2.5% of their portfolio
₹171.48 Cr
20,77,449 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
2.4% of their portfolio
₹165.58 Cr
20,77,449 sh
ICICI Prudential Manufacturing Fund
0.9% of their portfolio
₹60.82 Cr
7,36,850 sh
ICICI Prudential Small Cap Fund
0.4% of their portfolio
₹42.91 Cr
5,19,841 sh
ICICI Prudential Smallcap Fund
0.4% of their portfolio
₹41.05 Cr
5,15,066 sh
Aditya Birla Sun Life Pharma & Healthcare Fund
1.3% of their portfolio
₹12.16 Cr
1,61,057 sh
ICICI Prudential Children Fund
0.8% of their portfolio
₹11.56 Cr
1,40,000 sh
HDFC Retirement Savings Fund - Hybrid-Equity Plan
65.0% of their portfolio
₹10.44 Cr
1,25,000 sh
ICICI Prudential Child Care Fund (Gift Plan)
0.7% of their portfolio
₹10.02 Cr
1,20,000 sh
ICICI Prudential Children’s Fund
0.7% of their portfolio
₹10.02 Cr
1,20,000 sh
Chirayu Ramanbhai Amin HUF
Investor
₹1.39 Cr
98,268 sh
Groww Mutual Fund (scheme IB13)
0.7% of their portfolio
₹55.17 L
6,684 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
DSP Trustee Private Limited on behalf of schemes of DSP Mutual Fund
Alembic Pharmaceuticals Limited · NSE
−1,36,574 sh
ICICI Prudential Small Cap Fund
Alembic Pharmaceuticals Limited · NSE
5,19,841 sh · ₹42.91 Cr
Groww Mutual Fund (scheme IB13)
Alembic Pharmaceuticals Limited · NSE
6,684 sh · ₹55.17 L
ICICI Prudential Healthcare Fund
Alembic Pharmaceuticals Limited · NSE
20,77,449 sh · ₹171.48 Cr
ICICI Prudential Children Fund
Alembic Pharmaceuticals Limited · NSE
1,40,000 sh · ₹11.56 Cr
ICICI Prudential Manufacturing Fund
Alembic Pharmaceuticals Limited · NSE
7,36,850 sh · ₹60.82 Cr
ICICI Prudential Children’s Fund
Alembic Pharmaceuticals Limited · NSE
1,20,000 sh · ₹10.02 Cr
Groww Mutual Fund (scheme IB13)
Alembic Pharmaceuticals Limited · NSE
6,684 sh · ₹55.80 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
49 announcements on record for this company.
Promoter holding by quarter: Jun 2025 69.7%, Sep 2025 69.7%, Dec 2025 69.7%, Mar 2026 69.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 4.0%, Sep 2025 4.0%, Dec 2025 4.2%, Mar 2026 4.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 16.5%, Sep 2025 16.3%, Dec 2025 16.2%, Mar 2026 16.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 9.1%, Sep 2025 8.6%, Dec 2025 8.2%, Mar 2026 8.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
HDFC Mutual Fund (scheme HDFCRETHDP)
Alembic Pharmaceuticals Limited · NSE
5,000 sh · ₹41.75 L
HDFC Retirement Savings Fund - Hybrid-Equity Plan
Alembic Pharmaceuticals Limited · NSE
1,25,000 sh · ₹10.44 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 69.7%, Sep 2025 69.7%, Dec 2025 69.7%, Mar 2026 69.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 4.0%, Sep 2025 4.0%, Dec 2025 4.2%, Mar 2026 4.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 16.5%, Sep 2025 16.3%, Dec 2025 16.2%, Mar 2026 16.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 9.1%, Sep 2025 8.6%, Dec 2025 8.2%, Mar 2026 8.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
49 announcements on record for this company.